Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Banking And Finance | Small Cap
Health Score : 6.55Religare Enterprises operates within the Financial Services (Non-Bank Finance) sector. The company demonstrates notable strengths in solvency, efficiency, and profitability. Its revenue and asset growth are also positive. However, it shows weakness in liquidity and some financial metrics. While the company exhibits strong revenue and asset expansion, its profitability is mixed. The company's ability to meet its short-term obligations is questionable, and there are also concerns regarding earnings and capital expenditure. Future performance will depend on maintaining growth and improving financial stability.
Health Score : 6.55Religare Enterprises operates within the Financial Services (Non-Bank Finance) sector. The company demonstrates notable strengths in solvency, efficiency, and profitability. Its revenue and asset growth are also positive. However, it shows weakness in liquidity and some financial metrics. While the company exhibits strong revenue and asset expansion, its profitability is mixed. The company's ability to meet its short-term obligations is questionable, and there are also concerns regarding earnings and capital expenditure. Future performance will depend on maintaining growth and improving financial stability.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
-244.88
Industry Median
24.67
Small Cap Median
22.70
P/E RATIO
96.81
P/B RATIO
2.86
Industry Median
1.69
Small Cap Median
1.67
P/S RATIO
0.98
Industry Median
6.99
Small Cap Median
6.75
Others
PEG RATIO
5.76
EV/EBITDA RATIO
41.81
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹249.78 as on Sep 1, 2026.
Growth Score : 4.80The company exhibits mixed growth performance. While revenue and asset growth are strong, declines in operating profit, EPS, and net income growth are concerning. While the company shows strong revenue and asset expansion, its profitability is declining. Future success depends on turning its profitability around.
Revenue Growth RateExcellentOperating Profit Growth RatePoorEarnings Per Share (EPS) GrowthPoorAsset Growth RateExcellentNet Income Growth RatePoor| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 28.41 | 45 | 33.92 | 17.86 | 14.54 |
| Operating Profit Growth Rate | -230.94 | 232.69 | -23.81 | -3.26 | -61.8 |
| Earnings Per Share (EPS) Growth | -147.09 | 296.65 | -92.59 | -46.32 | -31.93 |
| Asset Growth Rate | 7.3 | -13.57 | 17.05 | 18.55 | 29.18 |
| Net Income Growth Rate | -221.97 | 305.91 | -89.05 | -47.26 | -60.11 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | ICRA Ltd | 9.12 | 26.65 | Neutral | 215.00 | 131.29 | 183.00 |
| 2 | Prudent Corporate Advisory Services Ltd | 8.93 | 62.51 | Neutral | 310.00 | 52.31 | 222.00 |
| 3 | CMS Info Systems Ltd | 7.76 | 13.44 | Undervalued | 596.00 | 17.79 | 303.00 |
| 4 | Religare Enterprises Ltd | 6.55 | 96.81 | Highly Overvalued | 136.00 | -0.99 | 73.00 |
| 5 | Edelweiss Financial Services Ltd | 6.47 | 22.31 | Neutral | 3090.00 | 4.73 | 680.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Hour Timeframe
Analyzing moving average trends and crossovers. Green/Red badges indicate if the current condition passes or fails.
Comparing stock price performance (normalized) against benchmark indices over time.
Recent daily trading volume represented as a bar chart, alongside historical averages.
Current closing price relative to the 52-week highest and lowest prices.
No Stock Reports Available at This Moment.
No Stock News Available at This Moment.
Religare Enterprises Ltd (REL) is an an Indian diversified financial services group with key interests in health insurance (Care Health Insurance), SME and retail lending (Religare Finvest Ltd.), and capital markets (Religare Broking Ltd.). The company aims to offer comprehensive financial solutions, driving profitable growth and business transformation.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Religare Enterprises Ltd's P/E ratio (TTM) is -244.88, compared to the industry median of 24.67 and large cap median of 22.70.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Religare Enterprises Ltd's P/B ratio is 2.86, compared to the industry median of 1.69 and large cap median of 1.67.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Religare Enterprises Ltd's P/S ratio is 0.98, compared to the industry median of 6.99 and large cap median of 6.75.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Religare Enterprises Ltd's PEG ratio is 5.76.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Religare Enterprises Ltd's EV/EBITDA ratio is 41.81.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Religare Enterprises Ltd's ROE is 2.51%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Religare Enterprises Ltd's ROA is 0.94%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Religare Enterprises Ltd's ROCE is 3%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Religare Enterprises Ltd's operating margin is 1.61%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Religare Enterprises Ltd's net margin is 0.86%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Religare Enterprises Ltd's current ratio is 0.29.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Religare Enterprises Ltd's debt-to-equity ratio is 0.18.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Religare Enterprises Ltd's interest coverage ratio is 3.42.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Religare Enterprises Ltd's DPS is ₹0.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Religare Enterprises Ltd's EPS is -31.93.
(Source line: "Ratios as of 24 Oct 2026, based on last traded price of ₹249.78. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 1984 (as Starteck Finance Limited)
Headquarters: New Delhi, Delhi
Core Offerings: Health Insurance, SME & Retail Lending, Broking & Capital Markets Advisory
Stock Listing: NSE (RELIGARE), BSE (532915)
Promoter: No clear promoter group in traditional sense; significant stake held by Burman Family
Religare Enterprises was incorporated in 1984 as Starteck Finance Limited. In 2007, it was renamed Religare Enterprises Ltd. and diversified into financial services, rapidly expanding its footprint across broking, wealth management, and lending. Following significant challenges and promoter issues involving Malvinder & Shivinder Singh, the company underwent a major restructuring. Currently, it focuses on strengthening its core businesses, especially health insurance, and has been subject to an ongoing open offer by the Burman Family to acquire control.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Care Health Insurance | 65-70% | Healthy margins |
| Lending (Religare Finvest Ltd.) | 20-25% | Under restructuring, lower profitability |
| Broking & Capital Markets | 5-10% | Stable margins |
Care Health Insurance (CHIL): A leading health insurer in India offering comprehensive health, critical illness, personal accident, and travel insurance products to diverse customer segments, emphasizing digital distribution.
Lending (Religare Finvest Ltd. - RFL): Engaged in small and medium enterprise (SME) and retail lending. Currently under a Corrective Action Plan by the RBI, focusing on asset quality improvement and debt resolution.
Broking & Capital Markets: Provides retail and institutional equity broking, investment advisory, portfolio management services, and other capital market solutions through its subsidiaries.
Dr. Rashmi Saluja - Executive Chairperson: An accomplished professional with extensive experience in financial services and healthcare, guiding the company's strategic vision and corporate governance.
['Care Health Insurance Ltd.', 'Religare Finvest Ltd.', 'Religare Broking Ltd.', 'Religare Capital Markets Ltd.']
Ongoing open offer by the Burman Family (Dabur Group) to acquire control of Religare Enterprises Ltd. Past debt restructuring of Religare Finvest Ltd.
The Religare Enterprises Ltd share price today is ₹249.78 on NSE (RELIGARE), as of 24 Oct 2026.
As of 24 Oct 2026, Religare Enterprises Ltd share price is ₹249.78, with previous close ₹249.78. Today's range is ₹249.78 to ₹249.78. The 52-week range is ₹N/A to ₹N/A.
As of today, Religare Enterprises Ltd's market cap is ₹8,317.67 crore (Mid Cap).
Religare Enterprises Ltd's current P/E ratio is -244.88, compared to the BANKING AND FINANCE sector average of 24.
Religare Enterprises Ltd's current P/B ratio is 2.86.
Religare Enterprises Ltd's current dividend yield is N/A. Last dividend of ₹0.00 per share was declared on N/A.
Religare Enterprises Ltd's EPS (TTM) is ₹-31.93.
Religare Enterprises Ltd (REL) is an an Indian diversified financial services group with key interests in health insurance (Care Health Insurance), SME and retail lending (Religare Finvest Ltd.), and capital markets (Religare Broking Ltd.). The company aims to offer comprehensive financial solutions, driving profitable growth and business transformation.
Religare Enterprises Ltd is promoted by No clear promoter group in traditional sense; significant stake held by Burman Family, holding 30.27% as of 24 Oct 2026.
Religare Enterprises Ltd is listed on NSE (RELIGARE) and BSE (532915). Its next quarterly results are expected on August 2024.
Financial Health & Prudence